United States Renal Data System: 2012 Annual Data Report. Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States; 2012.
http://www.usrds.org/adr.aspx webcite
Weiner DE: Public health consequences of chronic kidney disease.
Clin Pharmacol Ther 2009, 86:566-569.
Schedl A: Renal abnormalities and their developmental origin.
Nat Rev Genet 2007, 8:791-802.
Bonventre JV, Yang L: Cellular pathophysiology of ischemic acute kidney injury.
J Clin Invest 2011, 121:4210-4221.
Murugan R, Kellum JA: Acute kidney injury: whats the prognosis?
Nat Rev Nephrol 2011, 7:209-217.
Venkatachalam MA, Griffin KA, Lan R, Geng H, Saikumar P, Bidani AK: Acute kidney injury: a springboard for progression in chronic kidney disease.
Am J Physiol Renal Physiol 2010, 298:F178-F1094.
El Nahas AM, Bello AK: Chronic kidney disease: the global challenge.
Lancet 2005, 365:331-340.
Stocum DL: Stem cells in regenerative biology and medicine.
Wound Rep Reg 2001, 9:429-442.
Fioretto P, Steffes MW, Sutherland DER, Goetz FC, Mauer M: Reversal of lesions of diabetic nephropathy after pancreas transplantation.
N Engl J Med 1998, 339:69-75.
Fioretto P, Sutherland DER, Najafian B, Mauer M: Remodeling of renal interstitial and tubular lesions in pancreas transplant recipients.
Kidney Int 2006, 69:907-910.
Weissman IL: Stem cells: units of development, units of regeneration, and units in evolution.
Cell 2000, 100:157-168.
Yamanaka S, Blau HM: Nuclear reprogramming to a pluripotent state by three approaches.
Nature 2010, 465:704-712.
Hsu YC, Fuchs E: A family business: stem cell progeny join the niche to regulate homeostasis.
Nat Rev Mol Cell Bio 2012, 13:103-114.
Burness ML, Sipkins DA: The stem cell niche in health and malignancy.
Semin Cancer Biol 2010, 20:107-115.
Sharpless NE, DePinho RA: How stem cells age and why this makes us grow old.
Nat Rev Mol Cell Biol 2007, 8:703-713.
McCampbell KK, Wingert RA: Renal stem cells: fact or science fiction?
Biochem J 2012, 444:153-168.
Reilly RF, Bulger RE, Kriz W, In Diseases of the Kidney and Urinary Tract, Eighth Edition: Structural-functional relationships in the kidney. Philadelphia: Lippincott Williams & Wilkins: Edited by Schrier RW; 2007:2-53.
Little MH, Brennan J, Georgas K, Davies JA, Davidson DR, Baldock RA: A high-resolution anatomical ontology of the developing murine genitourinary tract.
Gene Expr Patterns 2007, 7:680-699.
Brunskill EW, Aronow BJ, Georgas K, Rumballe B, Valerius MT, Aronow J: Atlas of gene expression in the developing kidney at microanatomic resolution.
Dev Cell 2008, 15:781-791.
Mugford JW, Yu J, Kobayashi A, McMahon AP: High-resolution gene expression analysis of the developing mouse kidney defines novel cellular compartments within the nephron progenitor population.
Dev Biol 2009, 333:312-323.
Yu J, Valerius MT, Duah M, Staser K, Hansard JK, Guo JJ: Identification of molecular compartments and genetic circuitry in the developing mammalian kidney.
Development 2012, 139:1863-1873.
Wingert RA, Davidson AJ: The zebrafish pronephros: a model to study nephron segmentation.
Kidney Int 2008, 73:1120-1127.
Nyengaard JR, Bendtsen TF: Glomerular number and size in relation to age, kidney weight, and body surface in normal man.
Anat Rec 1992, 232:194-201.
Hughson M, Farris III: AB, Douglas-Denton R, Yoy WE, Bertram JF: Glomerular number and size in autopsy kidneys: the relationship to birth weight.
Kidney Int 2003, 63:2113-2122.
Potter EL, Thierstein ST: Glomerular development in the kidney as an index of fetal maturity.
J Pediatr 1943, 22:695-706.
Hartman HA, Lai HL, Patterson LT: Cessation of renal morphogenesis in mice.
Dev Biol 2007, 301:379-387.
Solomon S: Developmental changes in nephron number, proximal tubule length and superficial nephron glomerular filtration rate of rats.
J Physiol 1977, 272:573-589.
Wesson LG: Compensatory growth and other growth responses of the kidney.
Nephron 1989, 51:149-184.
de Rouffignac C, Monnens L: Functional and morphologic maturation of superficial and juxtamedullary nephrons in the rat.
J Physiol 1976, 262:119-129.
Spitzer A, Brandis M: Functional and morphologic maturation of the superficial nephrons.
J Clin Invest 1974, 53:279-287.
Blanpain C, Fuchs E: Epidermal homeostasis: a balancing act of stem cells in the skin.
Nat Rev Mol Cell Bio 2009, 10:207-217.
van der Flier LG, Clevers H: Stem cells, self-renewal, and differentiation in the intestinal epithelium.
Annu Rev Physiol 2009, 71:241-260.
Prescott LF: The normal urinary excretion rates of renal tubular cells, leucocytes and red blood cells.
Clin Sci 1966, 31:425-435.
Drrenhaus A, Mller JIF, Golka K, Jedrusik P, Schulze H, Fllmann W: Cultures of exfoliated epithelial cells from different locations of the human urinary tract and the renal tubular system.
Arch Toxicol 2000, 74:618-626.
Vogelmann SU, Nelson WJ, Myers BD, Lemley KV: Urinary excretion of viable podocytes in health and renal disease.
Am J Physiol Renal Physiol 2003, 285:F40-F48.
Rahmoune H, Thompson PW, Ward JM, Smith CD, Hong G, Brown J: Glucose transporters in human renal proximal tubular cells isolated from the urine in patients with non-insulin-dependent diabetes.
Diabetes 2005, 54:3427-3434.
Messier B, Leblond CP: Cell proliferation and migration as revealed by radioautography after injection of thymidine-H3 into male rats and mice.
Amer J Anat 1960, 106:247-285.
Maeshima A, Yamashita S, Nojima Y: Identification of renal progenitor-like tubular cells that participate in the regeneration processes of the kidney.
J Am Soc Nephrol 2003, 14:3138-3146.
Maeshima A, Sakurai H, Nigam SK: Adult kidney tubular cell population showing phenotypic plasticity, tubulogenic capacity, and integration capability into developing kidney.
J Am Soc Nephrol 2006, 17:188-198.
Vogetseder A, Karadeniz A, Kaissling B, Le Hir M: Tubular cell proliferation in the healthy rat kidney.
Histochem Cell Biol 2005, 124:97-104.
Vogetseder A, Palan T, Bacic D, Kaissling B, Le Hir M: Proximal tubular epithelial cells are generated by division of differentiated cells in the healthy kidney.
Am J Physiol Cell Physiol 2007, 292:C807-C813.
Vogetseder A, Picard N, Gaspert A, Walch M, Kaissling B, Le Hir M: Proliferation capacity of the renal proximal tubule involves the bulk of differentiated epithelial cells.
Am J Physiol Cell Physiol 2008, 294:C22-C28.
Nadasdy T, Laszik Z, Blick KE, Johnson LD, Silva FG: Proliferative activity of intrinsic cell populations in the normal human kidney.
J Am Soc Nephrol 1994, 4:2032-2039.
Hayslett JP, Kashgarian M, Epstein FH: Functional correlates of compensatory renal hypertrophy.
J Clin Invest 1968, 47:774-781.
Hostetter TH: Progression of renal disease and renal hypertrophy.
Annu Rev Physiol 1995, 57:263-278.
Cuppage FE, Tate A: Repair of the nephron following injury with mercuric chloride.
Am J Pathol 1967, 51:405-429.
Houghton DC, Hartnett M, Campbell-Boswell M, Porter G, Bennett W: A light and electron microscopic analysis of gentamicin nephrotoxicity in rats.
Am J Pathol 1976, 82:589-612.
Witzgall R, Brown D, Schwarz C, Bonventre JV: Localization of proliferating cell nuclear antigen, vimentin, c-Fos and clusterin in the postischemic kidney. Evidence for a heterogenous genetic response among nephron segments, and a large pool of mitotically active and dedifferentiated cells.
J Clin Invest 1994, 93:2175-2188.
Nadasdy T, Laszik Z, Blick KE, Johnson DL, Burst-Singer K, Nast C: Human acute tubular necrosis: a lectin and immunohistochemical study.
Hum Pathol 1995, 26:230-239.
Molitoris BA, Wilson PD, Schrier RW, Simon FR: Ischemia induces partial loss of surface membrane polarity and accumulation of putative calcium ionophores.
J Clin Invest 1985, 76:2097-2105.
Molitoris BA, Hoilien CA, Ahnen DJ, Wilson PD, Kim J: Characterization of ischemia-induced loss of epithelial polarity.
Read more from the original source:
Regenerative medicine for the kidney: stem cell prospects ...
- Hannah just thought she was being clumsy, but her bruises were a sign she needed to see her doctor - Daily Mail - October 27th, 2023
- Brent Rutemiller's Cancer In Early Remission After 42 Weeks of Chemotherapy and Stem Cell Transplant - Swimming World Magazine - May 20th, 2022
- Other Notable Health Studies & Research From May 17, 2022 - Study Finds - May 20th, 2022
- Clinton County Relay For Life holds annual event in Riverview Park - Lock Haven Express - May 20th, 2022
- Illinois Is Being Invaded By Worms That Jump A Foot In The Air - 1440wrok.com - May 20th, 2022
- Moderna, J&J COVID Booster Shots Near Authorization. Here's What to Know - NBC Chicago - October 26th, 2021
- GenFleet Announces First Patient Dosed in Phase Ib/II Trial of TGF- R1 Inhibitor in Combination with PD-1 Inhibitor in Global Multi-center Research -... - October 26th, 2021
- Merck Provides Update on KEYTRUDA (pembrolizumab) Indication in Third-Line Gastric Cancer in the US - Business Wire - July 6th, 2021
- Orchard Therapeutics and Pharming Group Announce Collaboration to Develop and Commercialize ex vivo autologous HSC Gene - GlobeNewswire - July 6th, 2021
- New global guidelines for stem cell research aim to drive discussions, not lay down the law - The Conversation AU - May 27th, 2021
- Merck (MRK) Granted Positive EU CHMP Opinion for KEYTRUDA (pembrolizumab) in Combination with Chemotherapy - StreetInsider.com - May 27th, 2021
- Merck Receives Positive EU CHMP Opinion for KEYTRUDA in Combination With Chemotherapy as First-Line Treatment for Certain Patients With Esophageal... - May 27th, 2021
- Epigenetic therapies for heart failure | VHRM - Dove Medical Press - May 27th, 2021
- OPDIVO (nivolumab) in Combination with CABOMETYX (cabozantinib) Shows Sustained Survival and Response Rate Benefits as First-Line Treatment for... - February 14th, 2021
- AlloVir Research Presented at the 2021 Transplantation & Cellular Therapy Meeting Digital Experience - Business Wire - February 14th, 2021
- Opdivo in Combination with Cabometyx Shows Sustained Survival and Response Rate Benefits as First-Line Treatment for Patients with Advanced RCC -... - February 14th, 2021
- Astellas and Seagen Announce Presentation of Results from PADCEV (enfortumab vedotin-ejfv) Pivotal Trial in Patients with Previously Treated Advanced... - February 14th, 2021
- [Full text] Loganin Attenuates Septic Acute Renal Injury with the Participation of | DDDT - Dove Medical Press - February 14th, 2021
- [Full text] Encephalopathy Induced by Preventive Administration of Acyclovir in a | IJGM - Dove Medical Press - February 14th, 2021
- Joint inflammation: Causes, treatment, and symptoms - Medical News Today - February 14th, 2021
- Creative Medical Technology Holdings Identifies and Files Patent on Novel Mechanism of ImmCelz Therapeutic Activity - PRNewswire - February 3rd, 2021
- How Coronavirus Damages Lung Cells Within Mere Hours And What Drugs Could Halt COVID-19 Infection - SciTechDaily - February 3rd, 2021
- Mini kidneys bioprinted in the lab - Lab + Life Scientist - December 4th, 2020
- Telix Pharmaceuticals Limited Acquires TheraPharm GmbH, Broadening Reach to Hematologic Cancers and Transplant Medicine - BioSpace - December 4th, 2020
- News briefing: Four biotechs announce IPO terms, setting the pace to round out a busy year; FDA sets PDUFA date for Kadmon's graft-versus-host drug -... - December 4th, 2020
- Government of Canada and JDRF Canada announce new research funding to accelerate stem cell-based therapies for type 1 diabetes - Philippine Canadian... - December 4th, 2020
- Merck Announces KEYNOTE-598 Trial Evaluating KEYTRUDA in Combination With Ipilimumab Versus KEYTRUDA Monotherapy in Certain Patients With Metastatic... - November 11th, 2020
- KEYTRUDA (pembrolizumab) Plus LENVIMA (lenvatinib) Demonstrated Statistically Significant Improvement in Progression-Free Survival (PFS), Overall... - November 11th, 2020
- Gilead and Kite to Share Latest Scientific Advances in Hematologic Malignancies at ASH 2020 - Investing News Network - November 11th, 2020
- The great reset: new danger on the horizon - Amandala - November 11th, 2020
- Teladoc Is A Strong Buy: A Radical Healthcare Change Will Come - Seeking Alpha - November 11th, 2020
- COVID Drug Given to Trump Developed From Aborted Fetus Cells - Quint Fit - October 10th, 2020
- Lars Jaeger: The Future is Veggie, With 3D Printing - finews.asia - October 10th, 2020
- Laid off from ImmunoGen, an ex-Genzyme and Shire exec heads to an ARCH upstart - Endpoints News - October 10th, 2020
- 5 Deadly Pre-existing Conditions You Could Have Due To COVID-19 - Brumpost - Brumpost - October 10th, 2020
- The Crypto Daily Movers and Shakers October 10th, 2020 - Sports Grind Entertainment - October 10th, 2020
- Coronavirus Tracker: Bexar Co. cases surpass 59,000; Texas hospitalizations trending in the wrong direction - KENS5.com - October 10th, 2020
- Ligand Announces its Captisol Business is Positioned for Major Growth and Forecasts 2021 Captisol Material Sales of $200 Million - Business Wire - September 24th, 2020
- Seattle Genetics and Merck Announce Two Strategic Oncology Collaborations - BioSpace - September 15th, 2020
- Alexion and Caelum Biosciences Announce Start of Phase 3 Studies of CAEL-101 in AL Amyloidosis - Business Wire - September 15th, 2020
- Braunstein Reflects on the Rise of Quadruplet Therapies in Multiple Myeloma - OncLive - September 9th, 2020
- Roche receives FDA clearance for BK virus quantitative test on cobas 6800/8800 Systems to support better care for transplant patients - GlobeNewswire - September 9th, 2020
- ASX Biotechs Surfing The Covid Story - FN Arena News - August 16th, 2020
- Merck and Eisai Receive Complete Response Letter for KEYTRUDA (pembrolizumab) plus LENVIMA (lenvatinib) Combination as First-Line Treatment for... - July 10th, 2020
- FDA Approves Talaris Therapeutics' IND for Its Allogeneic Cell Therapy FCR001 to Be Evaluated in Patients With a Severe Form of Scleroderma - Business... - July 10th, 2020
- Coronavirus PPP Loans In Livingston: Where The Money Went - Livingston, NJ Patch - July 9th, 2020
- Stem Cell Therapy For Kidney Failure. Learn More Now ... - July 7th, 2020
- Anemia in chronic kidney disease - kidneyfund.org - July 7th, 2020
- Dr Borehams Crucible: Mesoblast within months of 3 major trial results, key regulatory decision - Stockhead - July 7th, 2020
- FDA Approves Merck's KEYTRUDA (pembrolizumab) for First-Line Treatment of Patients With Unresectable or Metastatic MSI-H or dMMR Colorectal Cancer -... - June 30th, 2020
- R3 International Offering Stem Cell Therapy Program for Anti Aging in Mexico - PR Web - June 30th, 2020
- Vitro Bio-Pharma 2nd Quarter Ended April 30th 2020 Financial Results of Operations and Shareholder Letter - Stockhouse - June 30th, 2020
- FDA Approves Merck's KEYTRUDA (pembrolizumab) for the Treatment of Patients with Recurrent or Metastatic Cutaneous Squamous Cell Carcinoma (cSCC) that... - June 25th, 2020
- Simcha Therapeutics Launches to Engineer Therapeutic Cytokines to Unlock the Full Potential of the Immune System - Business Wire - June 25th, 2020
- First American to Receive Placental Cell Treatment For COVID-19 is an Acclaimed Broadway Scenic Designer - Science Times - May 27th, 2020
- Scientists generate millions of mature human cells, far more than have ever been produced - UB News Center - May 20th, 2020
- Heres The Reason Why Scientists Are Growing Human Cells In Mouse Embryo - Medical Daily - May 20th, 2020
- Cell therapies trial planned for COVID-19 - Mirage News - May 5th, 2020
- New Study Finds That Wearing Contact Lenses Doesn't Increase Risk of COVID-19 Infection - HealthDay Coronavirus Liveblog - April 26th, 2020
- Israeli COVID-19 treatment with 100% survival rate tested on US patient - The Jerusalem Post - April 15th, 2020
- Stem Cells and Chronic Kidney Disease | Mayo Clinic Center ... - April 11th, 2020
- Kidney Failure | Stem Cell Treatment in Tijuana Mexico - April 11th, 2020
- MESOBLAST PARTNERS WITH THE CARDIOTHORACIC SURGICAL TRIALS NETWORK ESTABLISHED BY THE U.S. NATIONAL INSTITUTES OF HEALTHS NATIONAL HEART, LUNG AND... - April 11th, 2020
- Merck Receives Priority Review from FDA for Second Application for KEYTRUDA (pembrolizumab) Based on Biomarker, Regardless of Tumor Type - Benzinga - April 11th, 2020
- A coronavirus vaccine is being developed in record time. But dont expect that technology to speed up flu vaccines yet. - Columbia Daily Herald - April 7th, 2020
- Researchers test drug that stops early stages of COVID-19 - Open Access Government - April 7th, 2020
- Can cell-based therapy be helpful in tackling coronavirus? - YourStory - March 25th, 2020
- Made-in-space organs could soon be reality - ETHealthworld.com - March 13th, 2020
- What Is the Coronavirus? - WIRED - March 6th, 2020
- 34 years with a new heart and counting - MDJOnline.com - February 25th, 2020
- Coronavirus: Doctors try 3,000-year-old Traditional Chinese Medicine (TCM) to treat the virus - Times of India - February 20th, 2020
- Merck's KEYTRUDA (pembrolizumab) in Combination with Chemotherapy Met Primary Endpoint of Progression-Free Survival (PFS) as First-Line Treatment for... - February 14th, 2020
- Seattle Genetics and Astellas Announce Updated Results from Phase 1b/2 Trial of PADCEV (enfortumab vedotin-ejfv) in Combination with Immune Therapy... - February 14th, 2020
- Omeros: 2 Major Catalysts On The Horizon - Seeking Alpha - February 10th, 2020
- Cambridge Science Festival showcases new research at the forefront of healthcare and medicine - Cambridge Network - February 10th, 2020
- Anemia: Causes, symptoms and treatment - Livescience.com - February 8th, 2020
- 4 Crazy but Effective Ways to Save More Money This Year - Nasdaq - February 4th, 2020
- BAME lives to be saved as new organ donation law rolls out - Keep the Faith - January 15th, 2020
- HIV drug resistance an emerging threat, expert warns - DAWN.com - January 10th, 2020
- A Lasting Legacy: DuPont, C8 Contamination and the Community Left to Grapple With the Consequences - alleghenyfront.org - January 10th, 2020